(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDICATION ADHERENCE IS OUR MISSION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDICATION ADHERENCE IS OUR MISSION

ST13

US500000086979193

Class

38, 42, 44

Filing

86979193

Registration

5009614

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

07/27/2025

Trademark type

Word

Nice classes

38, 42, 44

Filing date

03/19/2015

Registration date

07/26/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/07/2023

Last transaction

07/27/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2015-07-00

First use in commerce

2015-07-00

Drawing code

4

Owner type

16

Owner location

Owings Mills, MD

Examiner

FLOWERS, JAY

Law office

M30

Current location

TMO LAW OFFICE 112

Holders and representatives

Holders

Medherent, LLC

Representatives

Ned T. Himmelrich Gordon Feinblatt Llc

Technical classification

Nice Classes

Class 38Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 38

Electronic transmission of messages and data in the field of medical records and medication dosage and usage

Class 42

Computer servicesacting as an application service provider in the field of information management to host computer application software for the purpose of managing electronic medical records and medication dosage and usage and for providing automated reminderauthorizationalertmonitoring of medication dosagetracking patient medication usage and adherence

Class 44

Prescription refill reminder services; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposesincluding patient medication dosageusage and adherence

Publications

History of USPTO decisions and trademark events.

27 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/26/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/07/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/07/2023

E815

TEAS SECTION 8 & 15 RECEIVED

07/20/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/26/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/26/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/18/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/17/2016

DOCK

ASSIGNED TO EXAMINER

06/03/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/24/2016

DPCC

DIVISIONAL PROCESSING COMPLETE

05/24/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/22/2016

IUAF

USE AMENDMENT FILED

04/06/2016

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

04/06/2016

EISU

TEAS STATEMENT OF USE RECEIVED

04/06/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/06/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/11/2015

PUBO

PUBLISHED FOR OPPOSITION

08/11/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/22/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/09/2015

ALIE

ASSIGNED TO LIE

07/09/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/24/2015

DOCK

ASSIGNED TO EXAMINER

06/23/2015

DRRR

DIVISIONAL REQUEST RECEIVED

04/06/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/30/2015

NWAP

NEW APPLICATION ENTERED

03/23/2015

Continuous trademark protection

Get notified about every new filing that threatens MEDICATION ADHERENCE IS OUR MISSION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.